← Scroll for more →
Financial Statements — OBX
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q1 2025 | Q4 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.00 | -- | 40.41 | -- | 49.76 | -- |
| Short-term Investments | -- | -- | 40.08 | -- | 118.51 | -- |
| Total Current Assets | 0.00 | -- | 81.52 | -- | 172.85 | -- |
| Property, Plant & Equipment | -- | -- | 1.91 | -- | 3.32 | -- |
| Total Non-current Assets* | 0.00 | -- | 7.06 | -- | 10.87 | -- |
| Total Assets | 0.00 | -- | 88.58 | -- | 183.71 | -- |
| Accounts Payable | -- | -- | 0.01 | -- | 1.82 | -- |
| Total Current Liabilities | 0.00 | -- | 15.36 | -- | 16.09 | -- |
| Total Non-current Liabilities* | 0.00 | -- | 1.23 | -- | 4.03 | -- |
| Total Liabilities* | 0.00 | -- | 16.59 | -- | 20.12 | -- |
| Retained Earnings | 0.00 | -- | 295.94 | -- | 195.33 | -- |
| Total Stockholder Equity | 0.00 | (276.20) | (266.04) | (197.30) | (174.43) | (100.87) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Total Revenue | 0.00 | -- | 0.00 | -- |
| Research & Development | 21.55 | -- | 22.95 | -- |
| Selling, General & Admin | 4.59 | -- | 5.31 | -- |
| Total Operating Expenses | 26.14 | -- | 28.26 | -- |
| Operating Income | (26.14) | -- | (28.26) | -- |
| Pretax Income | (25.86) | -- | (26.90) | -- |
| Tax Provision | 0.00 | -- | 0.00 | -- |
| Net Income | 0.00 | (19.63) | (26.90) | (24.99) |
| Basic EPS | (1.19) | -- | (1.93) | -- |
| Diluted EPS | (1.19) | -- | (1.93) | -- |
← Scroll for more columns →
Cash Flow Statement
(USD)| Metric | Q2 2026 |
|---|---|
| Operating Cash Flow | 0.00 |
| Investing Cash Flow | 0.00 |
| Financing Cash Flow | 0.00 |
← Scroll for more columns →